Goldman Sachs Group Inc. Has $3.79 Million Holdings in Proto Labs, Inc. $PRLB

Key Points

• Goldman Sachs Group Inc. reduced its stake in Proto Labs by 56.8% during the first quarter, now owning approximately $3.79 million worth of shares.
• Several institutional investors have increased their positions in Proto Labs, with GAMMA Investing LLC leading with a 249.4% increase in holdings in the same period.
• Analyst reports have been positive, with Cantor Fitzgerald and Craig Hallum both raising their price targets, indicating a consensus rating of "Moderate Buy" for the stock.

Goldman Sachs Group Inc. lowered its position in Proto Labs, Inc. (NYSE:PRLB - Free Report) by 56.8% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 108,211 shares of the industrial products company's stock after selling 142,314 shares during the quarter. Goldman Sachs Group Inc. owned about 0.46% of Proto Labs worth $3,792,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in the company. Wellington Management Group LLP increased its stake in shares of Proto Labs by 97.4% in the first quarter. Wellington Management Group LLP now owns 711,738 shares of the industrial products company's stock valued at $24,939,000 after purchasing an additional 351,097 shares during the period. Connor Clark & Lunn Investment Management Ltd. increased its stake in shares of Proto Labs by 14.6% during the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 153,042 shares of the industrial products company's stock valued at $5,363,000 after acquiring an additional 19,441 shares during the period. Pacer Advisors Inc. increased its stake in shares of Proto Labs by 9,033.1% during the first quarter. Pacer Advisors Inc. now owns 148,595 shares of the industrial products company's stock valued at $5,207,000 after acquiring an additional 146,968 shares during the period. Principal Financial Group Inc. increased its stake in shares of Proto Labs by 2.7% during the first quarter. Principal Financial Group Inc. now owns 122,057 shares of the industrial products company's stock valued at $4,277,000 after acquiring an additional 3,168 shares during the period. Finally, Trexquant Investment LP increased its stake in shares of Proto Labs by 3.9% during the first quarter. Trexquant Investment LP now owns 107,154 shares of the industrial products company's stock valued at $3,755,000 after acquiring an additional 4,039 shares during the period. Institutional investors and hedge funds own 84.54% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on PRLB shares. Wall Street Zen upgraded shares of Proto Labs from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 2nd. Cantor Fitzgerald lifted their price target on shares of Proto Labs from $50.00 to $51.00 and gave the stock an "overweight" rating in a research report on Friday, August 1st. Finally, Craig Hallum upgraded shares of Proto Labs from a "hold" rating to a "buy" rating and set a $54.00 price target on the stock in a research report on Friday, August 1st. Two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $52.50.

Insider Activity

In related news, CEO Suresh Krishna bought 1,725 shares of the firm's stock in a transaction on Monday, August 4th. The stock was bought at an average price of $43.51 per share, with a total value of $75,054.75. Following the purchase, the chief executive officer directly owned 18,021 shares of the company's stock, valued at approximately $784,093.71. This represents a 10.59% increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 1.70% of the stock is owned by company insiders.

Proto Labs Price Performance

Proto Labs stock traded down $0.39 during midday trading on Friday, reaching $50.50. The stock had a trading volume of 589,021 shares, compared to its average volume of 151,804. The firm's fifty day simple moving average is $46.12 and its two-hundred day simple moving average is $40.39. Proto Labs, Inc. has a twelve month low of $26.34 and a twelve month high of $51.20. The firm has a market cap of $1.21 billion, a price-to-earnings ratio of 84.17 and a beta of 1.27.

Proto Labs (NYSE:PRLB - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The industrial products company reported $0.41 EPS for the quarter, topping analysts' consensus estimates of $0.33 by $0.08. Proto Labs had a net margin of 2.91% and a return on equity of 2.22%. The firm had revenue of $135.06 million during the quarter, compared to analyst estimates of $128.05 million. During the same quarter last year, the business posted $0.38 EPS. The company's revenue was up 7.6% on a year-over-year basis. Proto Labs has set its Q3 2025 guidance at 0.350-0.430 EPS. As a group, sell-side analysts predict that Proto Labs, Inc. will post 0.81 EPS for the current fiscal year.

About Proto Labs

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.